CVE-2022-1674: apple macos NULL Pointer Dereference
Vulnerability summary
CVE-2022-1674 is a medium (CVSS 6.6) NULL Pointer Dereference vulnerability in apple macos. EPSS estimates a 1.55% chance of exploitation in the next 30 days, higher than 74.6% of scored vulnerabilities. 1 public exploit is recorded.
Advisory lineage
Upstream 0 · Downstream 4 · Related 3Timeline
- 12-05-2022PublishedVulnerability first disclosed.
- 08-10-2026Last modifiedVulnerability information updated.
Description
NULL Pointer Dereference in function vim_regexec_string at regexp.c:2733 in GitHub repository vim/vim prior to 8.2.4938. NULL Pointer Dereference in function vim_regexec_string at regexp.c:2733 allows attackers to cause a denial of service (application crash) via a crafted input.
CVSS metrics
7 scores · 4 sources · 3 versions- OSV · DebianEcosystem advisory · calculated5.5MediumCVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:N/A:H
- NVDNIST5.5MediumCVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:N/A:H
- OSV · UbuntuEcosystem advisory · calculated6.6MediumCVSS:3.0/AV:L/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:H
- NVDNIST6.6MediumCVSS:3.0/AV:L/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:H
EPSS trend
Probability
1.55%
Chance of exploitation in the next 30 days
Percentile
75%
Versus all other CVEs
30-day change
0.00 pp
From 1.55% on 19-09-2026
Known exploited
Compare KEV catalogsNot in any of the 3 tracked catalogs.
Public exploits
1 foundExploit Reference (huntr.dev)
Maturity: unknown
Weaknesses
CWE · root causeAffected systems
Apple1 product
- macos< 13.0
Debian1 product
- vim< 2:9.0.0135-1
Fedoraproject1 product
- fedoraEOL34 | 35 | 36
Ubuntu1 product
- vim< 2:7.4.052-1ubuntu3.1+esm8 | < 2:7.4.1689-3ubuntu1.5+esm13 | < 2:8.0.1453-1ubuntu1.12 | < 2:8.1.2269-1ubuntu5.13 | < 2:8.2.3995-1ubuntu2.5
5 vendors · 6 products
References
16 links- lists.fedoraproject.org/archives/…Vendor Advisory
- lists.fedoraproject.org/archives/…Vendor Advisory
- lists.fedoraproject.org/archives/…Vendor Advisory
- seclists.org/fulldisclosure/2022/Oct/28Mailing List
- security.gentoo.org/glsa/202305-16Vendor Advisory
